Answers are grounded in this paper and cite their sources.
A novel graded AlGaN/AlN/GaN MOS-HEMT biosensor with dual cavity s is proposed for the label-free detection of SARS-CoV-2 spike (S) proteins and complementary DNA (c-DNA). The device incorporates a linearly graded barrier along with an ultrathin 1 nm AlN spacer layer to enhance polarization-induced charge density and improve the carrier confinement. The sensing mechanism relies on dielectric modulation and charge-induced electrostatic interactions within nanocavities beneath the gate, thereby modulating the channel characteristics. The simulation results obtained using Silvaco Atlas TCAD demonstrates that the inclusion of the AlN spacer layer reduces alloy scattering and increases sensitivity due to increased coupling between gate and channel region. For neutral S proteins, the threshold voltage sensitivity ( S V t h ) increases significantly from 14.75% to 48.77% as the dielectric constant rises from 2.1 to 4. In comparison, the maximum S V t h for c-DNA is 67.6% for dielectric constant of K=32. The study reveals that, an Al mole fraction of 0.15 and a barrier thickness of 15 nm optimize the sensing response by balancing carrier density with modulation depth. By reducing the thickness of the cavity down to 10 nm and increasing the cavity length to 700 nm maximizes the drain current sensitivity, ( S I D S ) due to enhanced capacitive coupling and the interaction area. The proposed sensor also exhibits linearity with R 2 value of 0.99 for varying filling rates. The practical implementation of the proposed device may face challenges such as fabrication complexity of ultrathin AlN spacer, control of cavity dimensions, and variations due to different binding conditions. The experimental validation and stability under various physiological conditions also remain critical considerations. Future work will focus on experimental work and extension toward multiplexed detection of diverse biomarkers to enable the development of highly sensitive, reliable, and scalable biosensor for point-of-care diagnostic applications.
No takes yet. Share an insight, caveat, or question.
Jose et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: